Eurofins Scientific SE

ERF: XPAR (FRA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
j%>LOCK|@>>TtLOCK|^grt@@m

Eurofins Earnings: Hub-and-Spoke Network Investments Deliver Good Results; Raise Fair Value by 7%

Eurofins Scientific reported 3.7% organic sales growth during 2025, in line with PitchBook consensus, while growth accelerated to 4.7% in the fourth quarter. Adjusted EBITDA margin expanded to 22.5% from 22.3%.

Sponsor Center